Access Unlocked Wednesday June 15, 2016 – In an effort to fight obesity, The Food and Drug Administration (FDA) have approved The AspireAssist system. The system consists of “food dumping,” a surgically-placed tube will be implanted in the stomach, draining a portion of the stomach contents after every meal.
According to The AspireAssist website, a thin tube will be placed in your stomach that connects the inside of your stomach directly to a discreet button on the outside of your abdomen. After each meal, the device enables you to empty, or “aspirate”, up to 30% of your meal into the toilet through this tube by connecting a small, handheld device to the button. The device is about the size of a smartphone, and stores away in a small case afterwards.
Side effects related to use of the AspireAssist include occasional indigestion, nausea, vomiting, constipation and diarrhea.
The endoscopic surgical placement of the gastric tube is associated with risks, including sore throat, pain, abdominal bloating, indigestion, bleeding, infection, nausea, vomiting, sedation-related breathing problems, inflammation of the lining of the abdomen, sores on the inside of the stomach, pneumonia, unintended puncture of the stomach or intestinal wall and death.